Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	473.27	429.43	367.25	539.4	200.71	369.6
Depreciation & Amortization	22.13	22.79	30.49	31.8	34.73	35.14
Other Amortization	0.38	0.38	0.4	0.51	0.82	0.68
Loss (Gain) From Sale of Assets	0.57	-	0.01	-	0	-11.33
Loss (Gain) From Sale of Investments	-60.46	-38.73	46.68	-241.86	22.7	-261.05
Loss (Gain) on Equity Investments	0.19	9.25	-52.09	-	-	-
Stock-Based Compensation	72.97	62.4	-	-	0.79	2.14
Other Operating Activities	13.32	-31.4	69.34	63.59	32.04	26.66
Change in Accounts Receivable	-20.28	-35.48	-93.36	-16.94	-51.1	-17.62
Change in Inventory	32.77	4.33	-10.95	19.22	-31.53	-21.28
Change in Accounts Payable	-31.42	18.28	1.8	-5.74	14.08	9.96
Change in Unearned Revenue	90.32	96.85	72.48	31.76	77.68	8.09
Change in Other Net Operating Assets	37.8	-1.76	8.29	0.01	18.27	-5.29
Operating Cash Flow	631.54	536.35	440.34	421.74	319.2	135.69
Operating Cash Flow Growth	8.25%	21.80%	4.41%	32.12%	135.25%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-0.92	-1.28	-4.85	-5.82	-3.19	-1.98
Sale of Property, Plant & Equipment	-	-	-	-	-	28.1
Sale (Purchase) of Intangibles	-0.1	-4.44	-0.71	-0.02	-2.41	-2.67
Investment in Securities	64.96	183.02	22.76	64.31	-279.19	-316.21
Other Investing Activities	-13.56	-43.03	-40.67	3.12	-2.52	-4.06
Investing Cash Flow	68.8	134.27	-23.46	61.6	-287.31	-296.83

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	250	-	-	-	-
Total Debt Issued	250	250	-	-	-	-
Short-Term Debt Repaid	-	-250	-	-	-	-
Long-Term Debt Repaid	-	-10.71	-11.59	-11.92	-11.11	-10.02
Total Debt Repaid	-60.36	-260.71	-11.59	-11.92	-11.11	-10.02
Net Debt Issued (Repaid)	189.64	-10.71	-11.59	-11.92	-11.11	-10.02
Issuance of Common Stock	0.27	0.27	0.02	4.04	2.37	745.29
Repurchase of Common Stock	-139.65	-349.42	-	-356.35	-	-
Common Dividends Paid	-339.21	-407.8	-440.03	-136.29	-309.49	-
Other Financing Activities	-0.53	17.54	-0.04	0.06	-1.2	-1.9
Financing Cash Flow	-289.49	-750.13	-451.64	-500.47	-319.43	733.36

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	410.85	-79.51	-34.77	-17.13	-287.53	572.22

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	630.63	535.07	435.49	415.92	316.02	133.7
Free Cash Flow Growth	8.96%	22.87%	4.70%	31.61%	136.35%	-
Free Cash Flow Margin	58.33%	52.59%	46.63%	54.84%	50.36%	30.47%
Free Cash Flow Per Share	6.53	5.79	4.67	4.39	3.30	1.40
Levered Free Cash Flow	519.32	406.49	290.39	304.48	219.61	100.32
Unlevered Free Cash Flow	519.84	407.07	290.47	304.6	219.92	100.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.83	0.92	0.13	0.2	0.51	0.62
Cash Income Tax Paid	94.32	118.93	68.57	19.66	31.17	0.04
Change in Working Capital	109.18	82.22	-21.74	28.3	27.4	-26.15

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error